publication venue for
- Identification of a diphtheria toxin‐like gene family beyond theCorynebacteriumgenus. 592:2693-2705. 2018
- Crystal structure of cGMP‐dependent protein kinase Iβ cyclic nucleotide‐binding‐B domain : Rp‐cGMPS complex reveals an apo‐like, inactive conformation. 591:221-230. 2017
- Composition and immunological significance of the upper respiratory tract microbiota. 590:3705-3720. 2016
- Botulinum neurotoxin homologs in non-Clostridium species. 589:342-348. 2015
- Tumor suppression. 588:2557-2557. 2014
- Tumor suppressor microRNAs: A novel non-coding alliance against cancer. 588:2639-2652. 2014
- Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle. 585:4025-4028. 2011
- Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase. 585:1061-1066. 2011
- Mycobacterial adenosine kinase is not a typical adenosine kinase. 583:2231-2236. 2009
- Identification and characterization of human ribokinase and comparison of its properties withE. coliribokinase and human adenosine kinase. 581:3211-3216. 2007
- Identification and characterization of RED120: A conserved PWI domain protein with links to splicing and 3′-end formation. 581:3087-3097. 2007
- Atomic determinants of state-dependent block of sodium channels by charged local anesthetics and benzocaine. 580:6027-6032. 2006
- The membrane bound bacterial lipocalin Blc is a functional dimer with binding preference for lysophospholipids. 580:4877-4883. 2006
- Sodium channel activators: Model of binding inside the pore and a possible mechanism of action. 579:4207-4212. 2005
- Tau protein binds single-stranded DNA sequence specifically - the proof obtained in vitro with non-equilibrium capillary electrophoresis of equilibrium mixtures. 579:1371-1375. 2005
- Identification of a hTid-1 mutation which sensitizes gliomas to apoptosis. 578:323-330. 2004
- Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine. 568:49-54. 2004
- Activation of theWT1tumor suppressor gene promoter by Pea3. 560:183-191. 2004
- Structural basis for the emission of violet bioluminescence from a W92F obelin mutant. 506:281-285. 2001
- From p63 to p53 across p73. 490:163-170. 2001
- Carbamoylphosphate requirement for synthesis of the active center of [NiFe]-hydrogenases. 488:9-12. 2001
- Studies of a putative ice-binding motif in winter flounder skin-type anti-freeze polypeptide. 453:331-334. 1999
- Undercarboxylation of recombinant prothrombin revealed by analysis of γ-carboxyglutamic acid using capillary electrophoresis and laser-induced fluorescence. 445:256-260. 1999
- Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation. 408:182-186. 1997
- Molecular and functional characterization of a partial cDNA encoding a novel chicken brain melatonin receptor. 374:273-278. 1995
- Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpin. 365:189-192. 1995
- Similarity of Ca2+ -bound conformations of morphine and Met-enkephalin: A computational study. 354:131-134. 1994
- Site-directed mutagenesis of the P2 residue of human antithrombin. 339:147-150. 1994
- Lysophosphatidylcholine mediates the mode of insertion of the NH2-terminal SIV fusion peptide into the lipid bilayer. 333:325-330. 1993
-
Growth response to 4-hydroxy-
l -threonine ofEscherichia colimutants blocked in vitamin B6biosynthesis. 318:125-128. 1993 - Coordinate regulation of murein peptidase activity and AmpC β-lactamase synthesis inEscherichia coli. 304:103-108. 1992
- Zwitterionic amphiphiles that raise the bilayer to hexagonal phase transition temperature inhibit protein kinase C The exception that proves the rule. 304:245-248. 1992
- The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. 298:206-210. 1992
- Site-directed mutagenesis of alanine-382 of human antithrombin III. 280:254-258. 1991
- The expression of interleukin-6 by a rat macrophage-derived cell line. 280:277-280. 1991
- Transforming growth factor-β and epidermal growth factor modulate basal and interleukin-6-induced amino acid uptake and acute phase protein synthesis in cultured rat hepatocytes. 266:48-50. 1990
- Phosphorus-containing inhibitors of aspartate transcarbamoylase fromEscherichia coli. 260:206-208. 1990
- Species-specific differences in the toxicity of puromycin towards cultured human and Chinese hamster cells. 234:141-144. 1988
- The bacteriophage Mu transposase protein can form high-affinity protein-DNA complexes with the ends of transposable elements of the Tn3family. 229:283-288. 1988
- Pseudo arylsulfatase A deficiency Biosynthesis of an abnormal arylsulfatase A. 219:130-134. 1987
- Patterns of gene expression during plasmacytoid differentiation of chronic lymphocytic leukaemia cells. 215:127-131. 1987
- Effect of electrostatic repulsion on the morphology and thermotropic transitions of anionic phospholipids. 209:257-260. 1986
- Membrane glycoprotein synthesis: cleavage of the signal sequence in the absence of glycosylation. 140:257-259. 1982
- Modifications in oocyte protein synthesis induced by progesterone in Xenopus laevis. 127:237-240. 1981
- CORRECTION. 131:189-189. 1981
- Stimulation of the release of prostaglandins from polymorphonuclear leukocytes by the calcium ionophore A23187. 86:255-258. 1978
- Studies on chemically modified forms of the myelin basic protein: Requirements for encephalitogenicity. 66:290-292. 1976
- Hepatic metabolism of hexachlorobenzene in rats. 51:225-226. 1975
- Cell-free synthesis of vesicular stomatitis virus proteins: Translation of membrane-bound polyribosomal mRNAs. 50:369-373. 1975
- Subunit interactions in aspartate transcarbamylase from Escherichia coli studied using matrix-bound derivatives. 44:178-181. 1974
- Affinity chromatography of porcine pancreatic ribonuclease reinvestigation of the N-terminal amino acid sequence. 31:181-185. 1973